Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

By: Joe Lindley Apr, 6 2026 0 Comments

Discover how the FDA monitors generic drugs after approval using systems like FAERS and the Sentinel Initiative to ensure long-term safety and efficacy.

View More